Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000899243-22-021636

Options or other derivatives

  • Director acquired 30,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Shegog Todd Director 2022-06-07 Grant or award · Stock Option (Right to Buy) +30,700 30,700 D: show line 1 in the form
Loading xslF345X03/doc4.xml…